| abstract |
The present invention provides a reliable and easy clinical marker for determining and / or predicting the therapeutic effect of an allergic disease, and a curative therapeutic agent particularly for the treatment of an allergic disease. A clinical marker for determining and / or predicting the therapeutic effect of an allergic disease using an antibody that recognizes apolipoprotein A-IV, a diagnostic method for allergic disease using the marker, and apolipoprotein A-IV Therapeutic agent for allergic diseases. [Selection figure] None |